Symbotic Inc.
Symbotic Inc. (SYM) Financial Performance & Income Statement Overview
Analyze Symbotic Inc. (SYM) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Symbotic Inc. (SYM) Income Statement & Financial Overview
Analyze Symbotic Inc.’s SYM earnings with segmented quarterly and yearly financial statement figures.
Metric | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 |
---|---|---|---|---|
Revenue | $549.65M | $486.69M | $503.57M | $470.34M |
Cost of Revenue | $441.82M | $406.65M | $439.57M | $415.37M |
Gross Profit | $107.83M | $80.04M | $63.99M | $54.97M |
Gross Profit Ratio | $0.20 | $0.16 | $0.13 | $0.12 |
R&D Expenses | $61.54M | $43.59M | $40.13M | $44.72M |
SG&A Expenses | $78.35M | $61.08M | $45.40M | $47.87M |
Operating Expenses | $139.89M | $104.67M | $85.53M | $92.59M |
Total Costs & Expenses | $581.71M | $511.32M | $525.10M | $507.96M |
Interest Income | $0.00 | $0.00 | $0.00 | $0.00 |
Interest Expense | $0.00 | $0.00 | $0.00 | $0.00 |
Depreciation & Amortization | $12.28M | $7.64M | $6.43M | $10.70M |
EBITDA | -$19.78M | -$16.98M | -$15.11M | -$26.92M |
EBITDA Ratio | -$0.04 | -$0.03 | -$0.03 | -$0.06 |
Operating Income | -$32.06M | -$24.63M | -$21.54M | -$37.62M |
Operating Income Ratio | -$0.06 | -$0.05 | -$0.04 | -$0.08 |
Other Income/Expenses (Net) | $11.71M | $7.82M | $9.42M | $11.62M |
Income Before Tax | -$20.34M | -$16.81M | -$12.12M | -$26.005M |
Income Before Tax Ratio | -$0.04 | -$0.03 | -$0.02 | -$0.06 |
Income Tax Expense | -$1.40M | $150000.00 | $4.19M | $182000.00 |
Net Income | -$3.92M | -$3.48M | -$2.49M | -$4.68M |
Net Income Ratio | -$0.007 | -$0.007 | -$0.005 | -$0.010 |
EPS | -$0.04 | -$0.03 | -$0.03 | -$0.02 |
Diluted EPS | -$0.04 | -$0.03 | -$0.03 | -$0.02 |
Weighted Avg Shares Outstanding | $107.73M | $106.10M | $104.15M | $102.41M |
Weighted Avg Shares Outstanding (Diluted) | $107.73M | $106.10M | $108.65M | $102.41M |
Over the last four quarters, Symbotic Inc. achieved steady financial progress, growing revenue from $470.34M in Q3 2024 to $549.65M in Q2 2025. Gross profit stayed firm with margins at 20% in Q2 2025 versus 12% in Q3 2024. Operating income totaled -$32.06M in Q2 2025, maintaining a -6% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at -$19.78M. Net income dropped to -$3.92M, with EPS at -$0.04. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan